Sodium Chloride Injection, Solution
NDC Package 17271-800-07

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Sodium Chloride injection is this solution is used to supply water and salt (sodium chloride) to the body. This formulation utilizes a injection, solution delivery system. Marketed by Becton Dickinson And Company, this product is identified by NDC 17271-800 and is authorized under FDA application ANDA213688.

Identification & Billing

NDC Package Code
17271-800-07
Package Description
6 BAG in 1 CASE / 1000 mL in 1 BAG
Product Code
17271-800
11-Digit Billing Format
17271080007
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Sodium Chloride
Non-Proprietary Name
Sodium Chloride
Substance Name
Sodium Chloride
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Irrigation - Administration to bathe or flush open wounds or body cavities.
Active Ingredient(s)
SODIUM CHLORIDE .9 g/100mL
Pharmacologic Class
Usage Information
This solution is used to supply water and salt (sodium chloride) to the body. Sodium chloride solution may also be mixed with other medications given by injection into a vein.

Regulatory & Marketing

Labeler Name
Becton Dickinson And Company
Product Type
Human Prescription Drug
FDA Application #
ANDA213688
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
11-14-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (17271-800). Click a package code to view its specific billing and regulatory data.

17271-800-08
5 BAG in 1 CASE / 2000 mL in 1 BAG
17271-800-09
4 BAG in 1 CASE / 3000 mL in 1 BAG

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 17271-800-07 identifies a specific commercial package of 6 bag in 1 case / 1000 ml in 1 bag of Sodium Chloride, a human prescription drug labeled by Becton Dickinson And Company. This injection, solution is formulated for irrigation use and contains sodium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Becton Dickinson And Company on November 14, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This solution is used to supply water and salt (sodium chloride) to the body. Sodium chloride solution may also be mixed with other medications given by injection into a vein.

How is this Becton Dickinson And Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 17271080007. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
17271-800-07
11-Digit CMS (5-4-2)
17271-0800-07

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.